We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Verrica

News List

Verrica Announces FDA Filing Acceptance for VP-102 for Molluscum Contagiosum americanpharmaceuticalreview
February 19, 2021
Verrica Pharmaceuticals announced its resubmitted New Drug Application (NDA) for VP-102 (cantharidin 0.7% Topical Solution), a proprietary topical therapy for the treatment of molluscum contagiosum (molluscum), has been accepted for filing by the ...
Verrica Licenses LTX-315 for Dermatologic Oncology Indications americanpharmaceuticalreview
August 17, 2020
Verrica Pharmaceuticals has entered into an exclusive worldwide license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatologic oncology indications.
Verrica seeks $86M IPO to take on compounded dermatology drug fiercebiotech
May 29, 2018
Verrica Pharmaceuticals has filed to raise $86 million from public investors. The planned IPO will give Verrica the money it needs to take a treatment for viral skin infection molluscum through phase 3 and onto the market.